. http://lm360.us/Mullinex-sister-of-Elifritz-from-Nov-Sedlice?Garrissis=106 eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention. . january 2013 (18) . your reason has been reported to the admin.